A phase I/II study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia: final analysis

20260 citationsJournal Articlegold Open Access

Authors

This trial was registered with the ClinicalTrials.gov identifier NCT02310321.

Published in: Therapeutic Advances in Hematology

Volume 17, pp. 20406207261419953-20406207261419953

Field-Weighted Citation Impact: 0.00